Hilltop Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Hilltop Partners's MRK Position: Q2 2026 in Review
Hilltop Partners increased its Merck (MRK) stake by 7.1% in Q2 2026, buying an estimated $94.1K and bringing the position to 12,139 shares worth $1.56M. The position accounts for 0.38% of the portfolio, ranked #45.
Hilltop Partners first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Hilltop Partners held 12,139 shares of Merck worth $1.56M as of Q2 2026.
- Hilltop Partners bought 804 Merck shares in Q2 2026, an estimated $94.1K.
- Merck made up 0.38% of Hilltop Partners's portfolio in Q2 2026, its #45 holding.
- Hilltop Partners first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Hilltop Partners's 13F filing for Q2 2026, filed 5 Aug 2026.